Fig. 9

A schematic depicting the mechanism involving HFD-mediated increase in DCA levels leading to dysregulation of ISC function and hepatic steatosis via ABL1‒YAP pathway
A schematic depicting the mechanism involving HFD-mediated increase in DCA levels leading to dysregulation of ISC function and hepatic steatosis via ABL1‒YAP pathway